Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches

Authors


  • Dr. Scadden is a consultant and shareholder in Fate Therapeutics, a consultant for Genzyme and a Scientific Advisory Board Member for Hospira. All other authors state that they have no conflicts of interest.

Ancillary